Intrinsic Value
Cyclacel Pharmaceuticals, Inc. (CYCCP)
$6.2
+0.30 (+5.08%)
| Enterprise Value | - |
|---|---|
| Net Debt | -36.56 |
| Equity Value | - |
| Shares Outstanding | 1.90 |
| Equity Value Per Share | - |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt